Raymond James Trust N.A. lifted its holdings in UnitedHealth Group Inc (NYSE:UNH) by 1.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 56,317 shares of the healthcare conglomerate’s stock after buying an additional 566 shares during the quarter. UnitedHealth Group makes up about 0.8% of Raymond James Trust N.A.’s holdings, making the stock its 24th biggest holding. Raymond James Trust N.A.’s holdings in UnitedHealth Group were worth $11,030,000 at the end of the most recent quarter.
Several other large investors have also added to or reduced their stakes in the company. Blue Chip Partners Inc. bought a new position in UnitedHealth Group in the 2nd quarter worth about $110,000. Bruderman Asset Management LLC bought a new position in UnitedHealth Group during the 2nd quarter valued at about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. lifted its stake in UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after acquiring an additional 520 shares during the period. BDO Wealth Advisors LLC bought a new position in UnitedHealth Group during the 2nd quarter valued at about $121,000. Finally, Kings Point Capital Management lifted its stake in UnitedHealth Group by 27.9% during the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after acquiring an additional 150 shares during the period. 86.01% of the stock is currently owned by hedge funds and other institutional investors.
Shares of UnitedHealth Group Inc (NYSE:UNH) traded up $3.25 on Friday, reaching $228.64. 3,934,738 shares of the company’s stock were exchanged, compared to its average volume of 2,940,000. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. UnitedHealth Group Inc has a twelve month low of $156.09 and a twelve month high of $231.77. The stock has a market cap of $221,060.00, a price-to-earnings ratio of 25.98, a P/E/G ratio of 1.53 and a beta of 0.66.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. The business had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The company’s revenue was up 8.7% on a year-over-year basis. During the same period last year, the firm posted $2.17 EPS. equities research analysts expect that UnitedHealth Group Inc will post 9.99 EPS for the current year.
Several research firms have issued reports on UNH. Jefferies Group restated a “buy” rating and set a $248.00 target price on shares of UnitedHealth Group in a research note on Friday, December 1st. Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, December 1st. Sanford C. Bernstein upped their target price on shares of UnitedHealth Group from $219.00 to $246.00 and gave the company an “outperform” rating in a research note on Friday, December 1st. Evercore ISI reaffirmed an “outperform” rating and set a $255.00 price target (up previously from $235.00) on shares of UnitedHealth Group in a research report on Friday. Finally, Goldman Sachs Group started coverage on shares of UnitedHealth Group in a research report on Wednesday, January 3rd. They set a “buy” rating and a $269.00 price target for the company. Three research analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $229.54.
In other news, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the completion of the transaction, the director now directly owns 61,137 shares in the company, valued at approximately $13,652,503.47. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Larry C. Renfro sold 22,598 shares of the stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $221.75, for a total value of $5,011,106.50. Following the transaction, the chief executive officer now owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The disclosure for this sale can be found here. Insiders have sold a total of 34,630 shares of company stock valued at $7,669,416 over the last quarter. Corporate insiders own 0.89% of the company’s stock.
WARNING: “Raymond James Trust N.A. Boosts Stake in UnitedHealth Group Inc (UNH)” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright law. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/01/13/unitedhealth-group-incorporated-unh-shares-bought-by-raymond-james-trust-n-a.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.